机构追踪 美股市场个股详情 TCBP TC BioPharm 添加自选 0.4530 +0.0525+13.11% 收盘价 01/13 16:00 (美东) 0.4599 +0.0069+1.52% 盘后19:59 (美东) 464.77万总市值0.00市盈率TTM 0.4693最高价0.3700最低价155.92万股成交量0.4000今开0.4005昨收65.24万成交额15.20%换手率0.00市盈率(静)1025.98万总股本26.160052...
$TC BioPharm(TCBP)$6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-047610 Act: 34 Size: 5 MB网页链接 增发股票注册声明 TC BioPharm(TCBP)2024-11-28 05:15 $TC BioPharm(TCBP)$F-3 Registration statement by foreign private issuers Accession Number: ...
TC BioPharm (Nasdaq: TCBP) is a publicly traded, clinical-stage cell therapy company developing advanced allogeneic CAR-T cell therapy products for the treatment of cancer.
最近访问:TC BioPharm (Holdings) plc ADR --- 全球指数美股行情美股吧国际期货 - -- 今开: - 最高价: - 成交量: - 外盘: - 昨收: - 最低价: - 成交额: - 内盘: - 总股本: - 振幅: - 换手率: - 每股收益TTM: - 总市值: - 市净率MRQ: - 市盈率TTM: - 每股净资产: - 美国经济数据>>...
苏格兰爱丁堡,2025年1月6日 /PRNewswire/ -- TC BioPharm(控股)有限公司("TC BioPharm"或"公司")(纳斯达克:TCBP)是一家临床阶段的生物技术公司,正在开发平台性同种异体 PR Newswire01/07 02:30 Neumora NMRA三期失败;TC生物制药谈判更新 BioPharmCatalyst01/03 02:31 板块更新:医疗保健 周二下午晚些时候,医疗...
百度股市通提供TC BioPharm (Holdings) PLC Sponsored ADR(TCBP)的行情报价、新闻资讯、股评、财报等信息,让用户在复杂的金融市场,更简单的获取投资信息。
Get a technical analysis of TC Biopharm (Holdings) Plc Sponsored ADR (TCBP) with the latest MACD of -0.64 and RSI of 23.01. Stay up-to-date on market trends with our expert analysis.
Arlene M. Morris is a businessperson who has been the head of 7 different companies and presently occupies the position of Chairman of TC Biopharm (Holdings) Plc and Chief Executive Officer for Willow Advisors LLC. Ms. Morris is also on the board of 6 other companies. She previously occupied...
Search Ticker | TCBP U.S.: Nasdaq TC BioPharm (Holdings) PLC ADRWatchlist Alert After Hours Last Updated: Jan 7, 2025 7:59 p.m. EST Delayed quote $ 0.4015 -0.01 -3.49% After Hours Volume: 41.76K CloseChgChg % $0.4160 0.0133 3.30% ...
TC Biopharm (Holdings) Plc Sponsored ADR stock news, updates & related news. Find out why TC Biopharm (Holdings) Plc Sponsored ADR's (TCBP) news sentiment is more negative in relation to stocks in the Healthcare sector.